During the past decade, finally, health care is starting to deal in a structured, measurable manner with the life factors and environments that play the biggest role in their patients’ health. A recent offering…
Continue Reading
Advancements in AI-driven healthcare and pharmaceuticals are reshaping the industry, evident through recent funding and collaborations. Peptris Technologies, backed by $1 million, expands AI drug discovery to rare diseases. Cipla boosts its stake in…
Continue Reading
Indian AI drug discovery firm gets $1M to focus on rare diseasesPeptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest.
In a statement, the AI-driven…
Circa 2023. We are in a world where AI and data science in pharma are exploding exponentially, and large amounts of data are being collected every single day. Unfortunately, there isn’t a clear way…
Continue Reading
What You Should Know:
Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven clinical-stage biotechnology company, today announced that the company has initiated the first-in-human study for ISM5411, a potentially first-in-class PHD inhibitor for the treatment…
Continue Reading
What You Should Know: Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital), joining existing investors Eli Lilly, NextStage…
Continue Reading
Wolters Kluwer Health offers a service called UpToDate, consulted by doctors around the world to help their clinical decision making. In this video, chief medical officer Peter Bonis explains how they are working to…
Continue Reading
Lance Hill, CEO of Within3
The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027, life science companies…
Continue Reading
Absci, a startup focused on developing generative AI antibody discovery technology, announced a potential $247 million partnership with pharma giant AstraZeneca to focus on expediting the discovery of novel cancer treatments with the help…
Continue Reading
From the discovery of penicillin in the early 20th century to the development of today’s cutting-edge biologics, the pharmaceutical industry has always been at the forefront of science and innovation.
Presently, this industry is grappling…
